Total planned funding: $4,618,423
Clear active filters
HTXD: Treatment: ARV Drugs
Own Agency
2006
2007
2008
2009
2010
2011
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Tanzania | $1,637,914 |
| South Africa | $1,019,594 |
| Rwanda | $405,999 |
| Mozambique | $274,142 |
| Zambia | $151,212 |
| Kenya | $136,368 |
| Uganda | $121,932 |
| Côte d'Ivoire | $121,624 |
| South Sudan | $114,666 |
| Malawi | $100,823 |
| Nigeria | $89,604 |
| Vietnam | $80,128 |
| Haiti | $74,696 |
| Asia Regional Program | $71,116 |
| Democratic Republic of the Congo | $64,360 |
| West Africa Region | $51,903 |
| Namibia | $42,614 |
| Eswatini | $33,895 |
| Burundi | $11,905 |
| Cameroon | $9,052 |
| Western Hemisphere Region | $4,876 |
Organizational Types
| Own Agency | $4,618,423 |
Program Areas
| Treatment | $4,618,423 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $4,618,423 |
Top Partner Programs
U.S. Centers for Disease Control and Prevention:
$1,271,836
View countries
All Countries
| 2019 | $1,271,836 |